Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (8 quarters reported)
$136M in Q4 2015 → $66.4M now. Hover for any quarter.
As reported for the quarter ended September 30, 2017. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| GP Gw Pharmaceuticals PLC | 5.6% | Added 9.8% | 36,847 | $3.74M |
| Incyte Corp | 4.9% | New | 27,887 | $3.26M |
| TP Teva Pharmaceutical Inds Ltd | 3.5% | New | 130,723 | $2.3M |
| Alnylam Pharmaceuticals Inc Call | 3.2% | New | 101,100 | $2.1M |
| T Tesaro Inc | 2.8% | Added 34% | 14,462 | $1.87M |
| CO Clovis Oncology Inc | 2.7% | Trimmed 48% | 21,787 | $1.8M |
| AG Alibaba Group Hldg Ltd | 2.6% | Unchanged | 9,900 | $1.71M |
| Vertex Pharmaceuticals Inc Call | 2.4% | Added 11% | 65,500 | $1.59M |
| CO Clovis Oncology Inc Call | 2.4% | Trimmed 42% | 84,200 | $1.56M |
| Akebia Therapeutics Inc Call | 2.2% | Added 26% | 190,400 | $1.45M |
| Puma Biotechnology Inc | 2.1% | New | 11,438 | $1.37M |
| T Tesaro Inc Put | 2.0% | Trimmed 11% | 31,000 | $1.34M |
| KP Kite Pharma Inc Call | 2.0% | Added 308% | 103,200 | $1.33M |
| GP Gw Pharmaceuticals PLC Put | 2.0% | Added 32% | 71,000 | $1.32M |
| CP Childrens Pl Inc | 2.0% | New | 11,000 | $1.3M |
| Insmed Inc Call | 1.9% | Added 217% | 222,000 | $1.28M |
| IT Ishares Tr | 1.8% | Trimmed 46% | 3,662 | $1.22M |
| IP Intercept Pharmaceuticals In | 1.8% | New | 20,264 | $1.18M |
| Kimberly Clark Corp | 1.7% | New | 9,700 | $1.14M |
| Nike Inc | 1.6% | New | 20,400 | $1.06M |
| Bristol Myers Squibb Co Call | 1.5% | Added 107% | 116,800 | $1.02M |
| SH Schein Henry Inc | 1.5% | New | 12,348 | $1.01M |
| Z Zogenix Inc | 1.4% | New | 26,778 | $939K |
| Gilead Sciences Inc | 1.4% | New | 11,581 | $938K |
| AP Alexion Pharmaceuticals Inc | 1.4% | New | 6,518 | $914K |
| AB Anheuser Busch Inbev Sa/nv | 1.3% | Trimmed 1.5% | 7,100 | $847K |
| AL Abbott Labs | 1.3% | Trimmed 68% | 15,800 | $843K |
| Dynavax Technologies Corp Call | 1.2% | Trimmed 27% | 50,700 | $796K |
| DT Dbv Technologies S A | 1.2% | New | 18,524 | $786K |
| AS Axovant Sciences Ltd Put | 1.2% | Added 826% | 274,100 | $782K |
| MI Mondelez Intl Inc | 1.1% | Trimmed 47% | 17,700 | $720K |
| Incyte Corp Put | 1.1% | Added 244% | 48,200 | $716K |
| V Versartis Inc Put | 1.0% | New | 91,400 | $694K |
| TW Time Warner Inc | 1.0% | Added 163% | 6,445 | $660K |
| O Otonomy Inc Put | 1.0% | Added 68% | 94,800 | $645K |
| Amicus Therapeutics Inc Call | 1.0% | Added 37% | 115,300 | $633K |
| Scynexis Inc | 0.9% | Unchanged | 241,236 | $581K |
| AT Aimmune Therapeutics Inc | 0.9% | New | 23,100 | $573K |
| Sarepta Therapeutics Inc | 0.9% | Trimmed 22% | 12,522 | $568K |
| Davita Inc | 0.8% | Trimmed 35% | 9,500 | $564K |
| Insmed Inc | 0.8% | Trimmed 0.0% | 17,953 | $560K |
| Regeneron Pharmaceuticals | 0.8% | Added 90% | 1,250 | $559K |
| TP Teva Pharmaceutical Inds Ltd Put | 0.8% | New | 229,100 | $518K |
| AS Axovant Sciences Ltd | 0.8% | Added 661% | 74,670 | $514K |
| RB Restaurant Brands Intl Inc | 0.8% | New | 7,900 | $505K |
| Abbvie Inc | 0.7% | New | 5,403 | $480K |
| CT Cascadian Therapeutics Inc | 0.7% | Trimmed 9.6% | 115,206 | $471K |
| ET Esperion Therapeutics Inc Ne | 0.7% | New | 8,825 | $442K |
| Z Zogenix Inc Call | 0.6% | New | 44,500 | $396K |
| WS Wal-mart Stores Inc | 0.6% | New | 5,000 | $391K |
| Sage Therapeutics Inc Put | 0.6% | Trimmed 23% | 57,200 | $374K |
| IP Intercept Pharmaceuticals In Put | 0.5% | New | 24,800 | $336K |
| CC Clorox Co Del | 0.5% | Trimmed 75% | 2,400 | $317K |
| Ptc Therapeutics Inc | 0.4% | New | 14,323 | $287K |
| D Dermira Inc Call | 0.4% | New | 101,700 | $282K |
| GM General Mls Inc | 0.4% | Trimmed 90% | 5,000 | $259K |
| Incyte Corp Call | 0.4% | Added 42% | 43,700 | $249K |
| AP Aerie Pharmaceuticals Inc | 0.4% | Added 16% | 5,060 | $246K |
| Intuitive Surgical Inc Call | 0.4% | Added 100% | 3,000 | $237K |
| V Versartis Inc | 0.3% | New | 91,440 | $224K |
Showing top 60 of 229 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 7 quarters.
quarter ended September 30, 2017 · filed November 13, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Incyte Corp | New | +27,887 | +$3.26M | 4.9% |
| GM General Mls Inc | Trimmed | −45,896 | −$2.38M | 0.4% |
| PP Portola Pharmaceuticals Inc | Exited | −41,187 | −$2.31M | — |
| TP Teva Pharmaceutical Inds Ltd | New | +130,723 | +$2.3M | 3.5% |
| Alnylam Pharmaceuticals Inc | New | +101,100 | +$2.1M | 3.2% |
| Amgen Inc | Exited | −12,082 | −$2.08M | — |
| AL Abbott Labs | Trimmed | −34,270 | −$1.83M | 1.3% |
| CO Clovis Oncology Inc | Trimmed | −19,713 | −$1.62M | 2.7% |
| Puma Biotechnology Inc | New | +11,438 | +$1.37M | 2.1% |
| CP Childrens Pl Inc | New | +11,000 | +$1.3M | 2.0% |
Showing the 10 largest of 288 changes.
quarter ended June 30, 2017 · filed August 11, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AL Abbott Labs | Trimmed | −110,900 | −$5.39M | 4.2% |
| CO Clovis Oncology Inc | Added | +37,679 | +$3.53M | 6.7% |
| CO Clovis Oncology Inc | Added | +131,700 | +$3.23M | 6.1% |
| Foot Locker Inc | Exited | −28,300 | −$2.12M | — |
| Amgen Inc | New | +12,082 | +$2.08M | 3.6% |
| GM General Mls Inc | Trimmed | −35,501 | −$1.97M | 4.9% |
| IT Ishares Tr | Added | +6,042 | +$1.87M | 3.6% |
| PP Portola Pharmaceuticals Inc | Added | +31,882 | +$1.79M | 4.0% |
| T Tesaro Inc | New | +10,805 | +$1.51M | 2.6% |
| Lululemon Athletica Inc | Exited | −26,500 | −$1.38M | — |
Showing the 10 largest of 336 changes.
quarter ended March 31, 2017 · filed May 12, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Regeneron Pharmaceuticals | Trimmed | −26,165 | −$10.2M | 0.3% |
| Jpmorgan Chase & Co | Exited | −41,500 | −$3.58M | — |
| Regeneron Pharmaceuticals | Trimmed | −97,600 | −$3.4M | 0.2% |
| Gilead Sciences Inc | Exited | −47,227 | −$3.38M | — |
| GP Gw Pharmaceuticals PLC | New | +25,829 | +$3.12M | 4.1% |
| Constellation Brands Inc | Trimmed | −17,582 | −$2.85M | 0.5% |
| KC Kellogg Co | Added | +29,852 | +$2.17M | 3.3% |
| Foot Locker Inc | New | +28,300 | +$2.12M | 2.8% |
| AP Alexion Pharmaceuticals Inc | Exited | −16,335 | −$2M | — |
| GM General Mls Inc | Added | +31,920 | +$1.88M | 6.7% |
Showing the 10 largest of 411 changes.
quarter ended December 31, 2016 · filed February 10, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| PA Procter And Gamble Co | Exited | −45,000 | −$4.04M | — |
| Bristol Myers Squibb Co | Exited | −73,537 | −$3.97M | — |
| Jpmorgan Chase & Co | New | +41,500 | +$3.58M | 4.1% |
| Constellation Brands Inc | New | +20,000 | +$3.07M | 3.5% |
| CO Clovis Oncology Inc | Exited | −71,091 | −$2.56M | — |
| GM General Mls Inc | Added | +36,971 | +$2.28M | 3.9% |
| Gilead Sciences Inc | Added | +30,806 | +$2.21M | 3.9% |
| IT Ishares Tr | Exited | −7,000 | −$2.03M | — |
| AP Alexion Pharmaceuticals Inc | New | +16,335 | +$2M | 2.3% |
| US Ulta Salon Cosmetcs & Frag I | Exited | −7,362 | −$1.75M | — |
Showing the 10 largest of 434 changes.
quarter ended September 30, 2016 · filed November 10, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| M Medivation Inc | Exited | −119,135 | −$7.18M | — |
| PA Procter And Gamble Co | Added | +44,000 | +$3.95M | 3.2% |
| Cal Maine Foods Inc | Exited | −82,081 | −$3.64M | — |
| Biogen Inc | Exited | −14,632 | −$3.54M | — |
| Apple Inc | Trimmed | −25,923 | −$2.93M | 0.3% |
| CO Clovis Oncology Inc | Added | +65,901 | +$2.38M | 2.0% |
| A Alere Inc | Exited | −53,163 | −$2.22M | — |
| Regeneron Pharmaceuticals | Added | +27,300 | +$2.09M | 4.5% |
| Bristol Myers Squibb Co | Added | +38,462 | +$2.07M | 3.1% |
| IT Ishares Tr | New | +7,000 | +$2.03M | 1.6% |
Showing the 10 largest of 468 changes.
quarter ended June 30, 2016 · filed August 12, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| M Medivation Inc | Added | +80,980 | +$4.88M | 6.2% |
| BI Baxter Intl Inc | Exited | −100,000 | −$4.11M | — |
| Biogen Inc | Added | +13,516 | +$3.27M | 3.0% |
| Cal Maine Foods Inc | Added | +59,189 | +$2.62M | 3.1% |
| Bristol Myers Squibb Co | New | +35,075 | +$2.58M | 2.2% |
| VP Valeant Pharmaceuticals Intl | Trimmed | −84,400 | −$2.57M | 1.3% |
| Apple Inc | Added | +23,487 | +$2.24M | 2.4% |
| Gilead Sciences Inc | Trimmed | −22,500 | −$1.88M | 0.4% |
| Biomarin Pharmaceutical Inc | New | +21,373 | +$1.66M | 1.4% |
| IB International Business Machs | Trimmed | −9,912 | −$1.49M | — |
Showing the 10 largest of 450 changes.
quarter ended March 31, 2016 · filed May 09, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Regeneron Pharmaceuticals | Added | +25,769 | +$9.29M | 12.5% |
| Gilead Sciences Inc | Trimmed | −97,843 | −$8.99M | 2.6% |
| C Celgene Corp | Exited | −54,834 | −$6.57M | — |
| D Dyax Corp | Exited | −168,700 | −$6.35M | — |
| Chipotle Mexican Grill Inc | Trimmed | −11,439 | −$5.39M | 1.0% |
| BI Baxter Intl Inc | New | +100,000 | +$4.11M | 4.3% |
| Akebia Therapeutics Inc | Added | +353,763 | +$3.19M | 3.7% |
| NG Newlink Genetics Corp | Trimmed | −51,800 | −$3.01M | 1.2% |
| DC Dow Chem Co | Exited | −51,300 | −$2.64M | — |
| MN Mylan N V | Exited | −47,500 | −$2.57M | — |
Showing the 10 largest of 388 changes.
Loading...
